Graybug Vision Stock

graybug.comHealthcare / Other HealthcareFounded: 2011Funding to Date: $160.77MM

Graybug Vision is a clinical-stage biopharmaceutical company focused on developing transformative medicines for the treatment of chronic diseases of the retina and optic nerve.

Register To Buy and Sell Shares

For more details on financing and valuation for Graybug Vision, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Graybug Vision’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Graybug Vision.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.


Management Team

Dan Salain
Chief Operating Officer
Charles Semba MD
Chief Medical Officer
Frédéric Guerard
Chief Executive Officer & Board Member
Peter Campochiaro MD
Justin Hanes Ph.D
Co-Founder & Board Member
Pamela Wapnick
Chief Financial Officer
Peter McDonnell MD

Board Members

Chau Khuong
Hansoo Keyoung
Cameron Wheeler Ph.D
Deerfield Management
Gerald Cagle Ph.D
Christy Shaffer Ph.D
Emmett Cunningham Ph.D
Clarus Ventures
Frédéric Guerard
Justin Hanes Ph.D

Frequently Asked Questions About Graybug Vision’s Stock

Can you buy Graybug Vision’s stock?
Graybug Vision is not publicly traded on NYSE or NASDAQ in the U.S. To buy Graybug Vision’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
Can you sell Graybug Vision’s stock?
Yes, you can sell stock of a private company like Graybug Vision. Forge can help you sell your Graybug Vision stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
What is Graybug Vision’s stock price?
Graybug Vision is a privately held company and therefore does not have a public stock price. However, you may access Graybug Vision’s private market stock price with Forge Data.
What is Graybug Vision’s stock ticker symbol?
Graybug Vision does not have an official ticker symbol because this company is not currently publicly traded.
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Graybug Vision Secures $80 million of Additional Funding to Advance its Potentially Transformative Retina and Glaucoma Clinical Programs
Graybug Vision, Inc., a clinical stage pharmaceutical company developing potentially transformative long-acting therapies for ocular diseases includin
Updated on: May 23, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.